skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: EBSCOhost Academic Search Premier remover Base de dados/Biblioteca: Elsevier ClinicalKey Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma
Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma

Alvares, L ; Kumar, P ; Muthukumar, M ; Lesperance, S ; Katsaounou, P

Value in health, 2017-10, Vol.20 (9), p.A652-A653 [Periódico revisado por pares]

Lawrenceville: Elsevier Science Ltd

Texto completo disponível

Citações Citado por
2
PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures
PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures
Material Type:
Artigo 		Adicionar ao Meu Espaço

PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures

Olafsson, G ; Mesterton, J ; Berenson, J.R ; Vrionis, F ; Alvares, L

Value in health, 2012-11, Vol.15 (7), p.A406-A406 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysis
PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysis

Stam, W ; Alvares, L ; Birinyi-strachan, L ; Maetzel, A

Value in health, 2011, Vol.14 (7), p.A245-A245 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
PMS78 Measurement Strategy for Kyphosis: New Evidence from Patients and Physicians
PMS78 Measurement Strategy for Kyphosis: New Evidence from Patients and Physicians
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMS78 Measurement Strategy for Kyphosis: New Evidence from Patients and Physicians

Bayliss, M.S ; Miltenburger, C ; Van de Maele, C ; Alvares, L ; Bujanover, S

Value in health, 2011, Vol.14 (7), p.A317-A317 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
PRS17 - Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
PRS17 - Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRS17 - Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients

Kaur, H ; Dongare, S ; Lijie, W ; Alvares, L

Value in health, 2018-09, Vol.21, p.S104-S104 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
PRS18 - Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
PRS18 - Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRS18 - Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan

Muthukumar, M ; Kozawa, M ; Alvares, L ; Milligan, K ; Igarashi, A

Value in health, 2018-09, Vol.21, p.S104-S105 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan

Muthukumar, M ; Kozawa, M ; Alvares, L ; Milligan, K ; Igarashi, A

Value in health, 2018-09, Vol.21, p.S104-S105 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients

Kaur, H ; Dongare, S ; Lijie, W ; Alvares, L

Value in health, 2018-09, Vol.21, p.S104 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
PRS74 - Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma
PRS74 - Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRS74 - Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma

Alvares, L ; Kumar, P ; Muthukumar, M ; Lesperance, S ; Katsaounou, P

Value in health, 2017-10, Vol.20 (9), p.A652-A653 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
PRS10 - POPULATION HEALTH IMPACT OF OMALIZUMAB OVER 11 YEARS OF USE IN IRELAND IN MODERATE TO SEVERE ALLERGIC ASTHMA
PRS10 - POPULATION HEALTH IMPACT OF OMALIZUMAB OVER 11 YEARS OF USE IN IRELAND IN MODERATE TO SEVERE ALLERGIC ASTHMA
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRS10 - POPULATION HEALTH IMPACT OF OMALIZUMAB OVER 11 YEARS OF USE IN IRELAND IN MODERATE TO SEVERE ALLERGIC ASTHMA

Corless, S. ; Alvares, L. ; Kumar, P. ; Muthukumar, M. ; Lesperance, S. ; Katsaounou, P.

Value in health, 2018-10, Vol.21, p.S405-S405 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.